Stay updated on Pimavanserin in Impulse Control Disorders Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.

Latest updates to the Pimavanserin in Impulse Control Disorders Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check25 days agoChange DetectedA banner announces NIH website changes and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.7%

- Check31 days agoChange DetectedThe website footer revision changed from v3.7.1 to v3.7.2; the study record content appears unchanged.SummaryDifference0.1%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded the revision entry Revision: v3.7.0 to the Record History and removed Revision: v3.6.6, updating the page's version history to reflect the latest update.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry labeled v3.6.6 has been added to the record history. The previous v3.6.5 entry has been removed.SummaryDifference0.1%

Stay in the know with updates to Pimavanserin in Impulse Control Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.